WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 2.7% of their position (4.35K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $6.9K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/22/2023ACC: 0001213900-23-089570
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+4.35K
Net shares
Net buyer
$6.9K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4.35K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.05K
Price / share
$1.60
Trade value
$6.48K
% of position
2.5%
11/20/2023
160.12K→164.17K
Common Stock
Direct
Shares
+300.00
Price / share
$1.56
Trade value
$468.00
% of position
0.2%
11/21/2023
164.17K→164.47K
Total
Net shares
+4.35K
Net value
$6.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2023 | P · Purchase | +4.05K | $1.60 | $6.48K | 2.5% | 160.12K | 164.17K |
| Common Stock Direct | 11/21/2023 | P · Purchase | +300.00 | $1.56 | $468.00 | 0.2% | 164.17K | 164.47K |
| Total | +4.35K | $6.95K | ||||||
Derivative Transactions0
No derivative transactions reported